From the Guidelines
Hormonal IUDs, such as Mirena, Liletta, or Skyla, are the most effective contraceptive methods for stopping periods, with many women experiencing amenorrhea over time 1. These methods work by maintaining consistent hormone levels that prevent the uterine lining from building up and shedding monthly.
- The levonorgestrel-releasing IUDs, such as Mirena, Liletta, or Skyla, are approved for 3-5 years, depending on the formulation, and have been shown to reduce menstrual bleeding by 40-50% and induce amenorrhea in a significant proportion of users 1.
- The copper IUD, on the other hand, is approved for 10 years, but data support its use for 12 years, and women will continue to have regular menstrual cycles, although these cycles may be heavier with more cramping initially 1.
- Other hormonal contraceptives, such as continuous or extended-cycle birth control pills, the birth control implant, and Depo-Provera injections, can also stop periods, but may not be as effective as hormonal IUDs in reducing menstrual bleeding 1. It is essential to consult with a healthcare provider to discuss medical history and determine the most appropriate option for specific needs, as the safety and efficacy of these methods can vary depending on individual circumstances 1.
From the FDA Drug Label
Most women using Medroxyprogesterone Acetate Injectable Suspension, USP experience disruption of menstrual bleeding patterns. ... As women continue using Medroxyprogesterone Acetate Injectable Suspension, USP, fewer experience irregular bleeding and more experience amenorrhea By month 12 amenorrhea was reported by 55% of women, and by month 24 amenorrhea was reported by 68% of women using Medroxyprogesterone Acetate Injectable Suspension, USP.
The contraceptive designed to stop periods is Medroxyprogesterone Acetate Injectable Suspension, USP, with amenorrhea reported by 55% of women by month 12 and 68% by month 24 2.
- Key points:
- Disruption of menstrual bleeding patterns is common
- Amenorrhea is experienced by a significant percentage of women
- The percentage of women experiencing amenorrhea increases over time 2 also indicates Medroxyprogesterone Acetate Injectable Suspension, USP is used for prevention of pregnancy, but does not provide additional information on menstrual bleeding patterns.
From the Research
Contraceptives Designed to Stop Period
- The levonorgestrel-releasing intrauterine system (LNG-IUS) is a contraceptive that can stop or reduce menstrual bleeding 3, 4, 5.
- Studies have shown that the LNG-IUS is effective in reducing menstrual blood loss and is a suitable option for women with heavy menstrual bleeding 3 or endometrial hyperplasia 5.
- The LNG-IUS has also been compared to medroxyprogesterone acetate, with results indicating that the LNG-IUS is more effective in reducing menstrual blood loss and improving hemoglobin levels 3, 4.
- Another study found that the use of the LNG-IUS was associated with a higher treatment response rate and a lower proportion of patients with progression of endometrial hyperplasia compared to medroxyprogesterone acetate 5.
- In terms of contraceptive options, women who choose the LNG-IUS or the etonogestrel implant are less likely to be currently experiencing intimate partner violence and are more likely to have finished high school and used the pill before 6.
Comparison of Contraceptives
- The LNG-IUS has been compared to other contraceptives, including medroxyprogesterone acetate and the etonogestrel implant, with varying results 3, 4, 5, 6.
- Medroxyprogesterone acetate has been associated with an increased risk of venous thrombosis, while the LNG-IUS has not been shown to increase this risk 7.
- The choice of contraceptive method can depend on various factors, including past contraceptive use, feelings towards pregnancy, stress, and weight 6.